• Blog
  • Pricing
  • Contact
  • FAQ
Sign InSign Up
AI Agent for Financial MarketsAsk anything. Our AI Agent brings real-time data and full market coverage.Open chat
MarketsStocksCryptoForexCommoditiesCalendarInsiders
TARA

TARA

Protara Therapeutics, Inc.

NASDAQHealthcareBiotechnologyUS

USD4.22

-0.12 (-2.76%)

Rating:B-

Company Profile

CEO

Jesse Shefferman

IPO Date

2014-10-22

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

Country

US

Market Metrics

Open

$4.42

Prev. Close

$4.34

Day Low

$4.19

Day High

$4.42

52W Low

$2.77

52W High

$7.82

Market Cap

$0.16B

Volume

0.51M

OverviewFinancialsRatingsInsidersSentimentsChart Patterns
News SentimentNeutral

Articles

7

Avg Positive

10.4%

Avg Negative

15.3%

Avg Neutral

74.6%

News Feed

New Strong Sell Stocks for June 29th

Zacks Investment Research·6/29/2021·↑ positive

TARA Stock: Over 7% Decrease Pre-Market Explanation

Pulse2·4/23/2021·↓ negative

Protara Therapeutics Provides Regulatory Update for TARA-002 for the Treatment of Lymphatic Malformations

GlobeNewsWire·4/23/2021·↑ positive

Protara Therapeutics Announces Appointment of Martín Sebastian Olivo, M.D. as Chief Medical Officer

GlobeNewsWire·4/19/2021·↑ positive

Protara Therapeutics Announces Appointment of Cynthia Smith to Board of Directors

GlobeNewsWire·2/2/2021·↑ positive

Protara Therapeutics Announces Promotion of Jacqueline Zummo, Ph.D., to Chief Scientific Operations Officer

GlobeNewsWire·12/7/2020·↑ positive

Protara Therapeutics to Present at the Jefferies Virtual London Healthcare Conference

GlobeNewsWire·11/11/2020·↑ positive